Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
van Kempen, Zoé L. E.
428  Ergebnisse:
englisch X
Personensuche X
?
1

T cell activation markers CD38 and HLA-DR indicative of non..:

Verstegen, Niels J M ; Hagen, Ruth R ; Kreher, Christine...
Journal of Neurology, Neurosurgery & Psychiatry.  , 2024
Link: https://doi.org/10.1136/..
 
?
2

Clinical and humoral responses after SARS-CoV-2 breakthroug..:

Stalman, Eileen W. ; Wieske, Luuk ; Keijser, Jim B.D....
Journal of Allergy and Clinical Immunology.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Suppressed IgG4 class switching in dupilumab‐ and TNF inhib..:

Valk, Anika M. ; Keijser, Jim B. D. ; van Dam, Koos P. J....
Allergy.  , 2024
Link: https://doi.org/10.1111/..
 
?
4

Primary SARS-CoV-2 infection in patients with immune-mediat..:

van Dam, Koos P. J. ; Volkers, Adriaan G. ; Wieske, Luuk...
BMC Infectious Diseases.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
5

Disease activity in patients with immune-mediated inflammat..:

van Dam, Koos P.J. ; Wieske, Luuk ; Stalman, Eileen W....
Journal of Autoimmunity.  135 (2023)  - p. 102984 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Extended interval dosing of ocrelizumab modifies the repopu..:

Rodriguez-Mogeda, Carla ; van Lierop, Zoë Y. G. J. ; van der Pol, Susanne M. A....
Journal of Neuroinflammation.  20 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
7

Humoral responses after second and third SARS-CoV-2 vaccina..:

Wieske, Luuk ; van Dam, Koos P J ; Steenhuis, Maurice...
The Lancet Rheumatology.  4 (2022)  5 - p. e338-e350 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV‐2..:

van Kempen, Zoé L. E. ; Hogenboom, Laura ; Toorop, Alyssa A....
Annals of Neurology.  93 (2022)  1 - p. 103-108 , 2022
Link: https://doi.org/10.1002/..
 
?
9

Severe breakthrough COVID-19 after SARS-CoV-2 booster vacci..:

van Kempen, Zoé L.E. ; Kummer, Laura Y.L. ; Wieske, Luuk...
Neuroimmunology Reports.  2 (2022)  - p. 100072 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Vaccination responses in B‐cell‐depleted multiple sclerosis..:

Killestein, Joep ; van Kempen, Zoé L. E.
European Journal of Neurology.  29 (2022)  11 - p. 3137-3138 , 2022
Link: https://doi.org/10.1111/..
 
?
11

Risk factors associated with short-term adverse events afte..:

Wieske, Luuk ; Kummer, Laura Y. L. ; van Dam, Koos P. J....
BMC Medicine.  20 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
12

Serum Neurofilament Light Association With Progression in N..:

Bridel, Claire ; Leurs, Cyra E. ; van Lierop, Zoë Y.G.J....
Neurology.  97 (2021)  19 - p. , 2021
Link: https://doi.org/10.1212/..
 
?
13

Varicella zoster-associated acute retinal necrosis and cent..:

van Kempen, Zoé L.E. ; van Rossum, Johannis A. ; Hoogervorst, Erwin...
Multiple Sclerosis and Related Disorders.  50 (2021)  - p. 102838 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Personalized extended interval dosing of natalizumab in MS:..:

van Kempen, Zoé L.E. ; Hoogervorst, Erwin L.J. ; Wattjes, Mike P....
Neurology.  95 (2020)  6 - p. , 2020
Link: https://doi.org/10.1212/..
 
?
15

Anti-natalizumab antibodies during 8 years of natalizumab t..:

van Kempen, Zoé L. E. ; van Rossum, Johannis A. ; Doesburg, Djoeke...
Journal of Neurology.  266 (2019)  7 - p. 1804-1805 , 2019
Link: https://doi.org/10.1007/..
 
1-15